Research needs to improve hypertension treatment and control in African Americans

Hypertension

Volumn 68, Issue 5, 2016, Pages 1066-1072

  Whelton, Paul K ^a,b   Einhorn, Paula T ^c   Muntner, Paul ^d   Appel, Lawrence J ^e   Cushman, William C ^f   Roux, Ana V Diez ^g   Ferdinand, Keith C ^a,b   Rahman, Mahboob ^h   Taylor, Herman A ⁱ   Ard, Jamy ^j   Arnett, Donna K ^k   Carter, Barry L ^l   Davis, Barry R ^m   Freedman, Barry I ^j   Cooper, Lisa A ^e   Cooper, Richard ⁿ   Desvigne Nickens, Patrice ^c   Gavini, Nara ^c   Go, Alan S ^o   Hyman, David J ^p   Kimmel, Paul L ^q   Margolis, Karen L ^r   Miller, Edgar R ^e   Mills, Katherine T ^y   Mensah, George A ^c   Navar, Ann M ^s   Ogedegbe, Gbenga ^t   Rakotz, Michael K ^u   Thomas, George ^b,v   Tobin, Jonathan N ^w   Wright, Jackson T ^h   Yoon, Sung Sug Sarah ^x   Cutler, Jeffrey A ^c   more..

^a TULANE UNIVERSITY   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g DREXEL UNIVERSITY   (United States)

^h CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ MOREHOUSE SCHOOL OF MEDICINE   (United States)

^j WAKE FOREST SCHOOL OF MEDICINE   (United States)

^k UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

^l UNIVERSITY OF IOWA   (United States)

^m UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

ⁿ LOYOLA UNIVERSITY CHICAGO   (United States)

^o DIVISION OF RESEARCH   (United States)

^p BAYLOR COLLEGE OF MEDICINE   (United States)

^q NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^r Health Partners   (United States)

^s DUKE UNIVERSITY MEDICAL CENTER   (United States)

^t NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^u AMERICAN MEDICAL ASSOCIATION   (United States)

^v LERNER RESEARCH INSTITUTE   (United States)

^w ROCKEFELLER UNIVERSITY   (United States)

^x NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

^y NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT; ANTIHYPERTENSIVE AGENT;

AFRICAN AMERICAN; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CLINICAL OUTCOME; HEREDITY; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; MEDICAL RESEARCH; PRIORITY JOURNAL; REVIEW; SOCIAL PSYCHOLOGY; ADULT; AGE DISTRIBUTION; AGED; CAUCASIAN; COMPARATIVE STUDY; EPIDEMIOLOGY; ETHNOLOGY; FEMALE; GENETICS; HEALTH CARE DISPARITY; MALE; MIDDLE AGED; NEEDS ASSESSMENT; PATHOPHYSIOLOGY; PREVALENCE; PROCEDURES; SEVERITY OF ILLNESS INDEX; SEX RATIO; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADULT; AFRICAN AMERICANS; AGE DISTRIBUTION; AGED; ANTIHYPERTENSIVE AGENTS; BIOMEDICAL RESEARCH; BLOOD PRESSURE DETERMINATION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTHCARE DISPARITIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NEEDS ASSESSMENT; PREVALENCE; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; UNITED STATES;

EID: 85047289156     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.116.07905     Document Type: Review

References (77)

1. Flack JM, Sica DA, Bakris G, Brown AL, Ferdinand KC, Grimm RH Jr, Hall WD, Jones WE, Kountz DS, Lea JP, Nasser S, Nesbitt SD, Saunders E, Scisney-Matlock M, Jamerson KA; International Society on Hypertension in Blacks. Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement. Hypertension. 2010;56:780-800. doi: 10.1161/HYPERTENSIONAHA.110.152892.
2. Cooper RS, Forrester TE, Plange-Rhule J, Bovet P, Lambert EV, Dugas LR, Cargill KE, Durazo-Arvizu RA, Shoham DA, Tong L, Cao G, Luke A. Elevated hypertension risk for African-origin populations in biracial societies: modeling the Epidemiologic Transition Study. J Hypertens. 2015;33:473-80; discussion 480. doi: 10.1097/HJH.0000000000000429.
3. Yoon SS, Carroll MD, Fryar CD. Hypertension prevalence and control among adults: United States, 2011-2014. NCHS Data Brief. 2015:1-8.
4. Whelton PK. The elusiveness of population-wide high blood pressure control. Annu Rev Public Health. 2015;36:109-130. doi: 10.1146/ annurev-publhealth-031914-122949.
5. Leenen FH, Dumais J, McInnis NH, Turton P, Stratychuk L, Nemeth K, Moy Lum-Kwong M, Fodor G. Results of the Ontario survey on the prevalence and control of hypertension. CMAJ. 2008;178:1441-1449. doi: 10.1503/cmaj.071340.
6. Nazroo JY, Falaschetti E, Pierce M, Primatesta P. Ethnic inequalities in access to and outcomes of healthcare: analysis of the Health Survey for England. J Epidemiol Community Health. 2009;63:1022-1027. doi: 10.1136/jech.2009.089409.
7. Agyemang C, Bindraban N, Mairuhu G, Montfrans Gv, Koopmans R, Stronks K; SUNSET (Surinamese in The Netherlands: Study on Ethnicity and Health) Study Group. Prevalence, awareness, treatment, and control of hypertension among Black Surinamese, South Asian Surinamese and White Dutch in Amsterdam, The Netherlands: the SUNSET study. J Hypertens. 2005;23:1971-1977.
8. Rayner B. Hypertension: detection and management in South Africa. Nephron Clin Pract. 2010;116:c269-c273. doi: 10.1159/000318788.
9. Cooper RS, Wolf-Maier K, Luke A, Adeyemo A, Banegas JR, Forrester T, Giampaoli S, Joffres M, Kastarinen M, Primatesta P, Stegmayr B, Thamm M. An international comparative study of blood pressure in populations of European vs.African descent. BMC Med. 2005;3:2. doi: 10.1186/1741-7015-3-2.
10. Modesti PA, Reboldi G, Cappuccio FP, Agyemang C, Remuzzi G, Rapi S, Perruolo E, Parati G; ESH Working Group on CV Risk in Low Resource Settings. Panethnic differences in blood pressure in Europe: a systematic review and meta-analysis. PLoS One. 2016;11:e0147601. doi: 10.1371/ journal.pone.0147601.
11. Klag MJ, Whelton PK, Coresh J, Grim CE, Kuller LH. The association of skin color with blood pressure in US blacks with low socioeconomic status. JAMA. 1991;265:599-602.
12. Ordúñez P, Kaufman JS, Benet M, Morejon A, Silva LC, Shoham DA, Cooper RS. Blacks and Whites in the Cuba have equal prevalence of hypertension: confirmation from a new population survey. BMC Public Health. 2013;13:169. doi: 10.1186/1471-2458-13-169.
13. Mosley JD, Appel LJ, Ashour Z, Coresh J, Whelton PK, Ibrahim MM. Relationship between skin color and blood pressure in egyptian adults: results from the national hypertension project. Hypertension. 2000;36:296-302.
14. Mc Donald Posso AJ, Motta Borrel JA, Fontes F, Cruz Gonzalez CE, Pachón Burgos AA, Cumbrera Ortega A. High blood pressure in Panama: prevalence, sociodemographic and biologic profile, treatment, and control (STROBE). Medicine (Baltimore). 2014;93:e101. doi: 10.1097/ MD.0000000000000101.
15. Gu Q, Burt VL, Dillon CF, Yoon S. Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health And Nutrition Examination Survey, 2001 to 2010. Circulation. 2012;126:2105-2114. doi: 10.1161/ CIRCULATIONAHA.112.096156.
16. Cushman WC, Ford CE, Einhorn PT, et al; ALLHAT Collaborative Research Group. Blood pressure control by drug group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Clin Hypertens (Greenwich). 2008;10:751-760. doi: 10.1111/j.1751-7176.2008.00015.
17. Fletcher RD, Amdur RL, Kolodner R, McManus C, Jones R, Faselis C, Kokkinos P, Singh S, Papademetriou V. Blood pressure control among US veterans: a large multiyear analysis of blood pressure data from the Veterans Administration health data repository. Circulation. 2012;125:2462-2468. doi: 10.1161/CIRCULATIONAHA.111.029983.
18. Sim JJ, Handler J, Jacobsen SJ, Kanter MH. Systemic implementation strategies to improve hypertension: the Kaiser Permanente Southern California experience. Can J Cardiol. 2014;30:544-552. doi: 10.1016/j. cjca.2014.01.003.
19. Kaufman JS, Dolman L, Rushani D, Cooper RS. The contribution of genomic research to explaining racial disparities in cardiovascular disease: a systematic review. Am J Epidemiol. 2015;181:464-472. doi: 10.1093/aje/kwu319.
20. Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, Roccella EJ, Stout R, Vallbona C, Winston MC, Karimbakas J; National High Blood Pressure Education Program Coordinating Committee. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA. 2002;288:1882-1888.
21. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572. doi: 10.1001/jama.289.19.2560.
22. Graudal NA, Hubeck-Graudal T, Jürgens G. Effects of low-sodium diet vs.high-sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride (Cochrane Review). Am J Hypertens. 2012;25:1-15. doi: 10.1038/ajh.2011.210.
23. Whelton PK, He J, Cutler JA, Brancati FL, Appel LJ, Follmann D, Klag MJ. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA. 1997;277:1624-1632.
24. Svetkey LP, Simons-Morton D, Vollmer WM, Appel LJ, Conlin PR, Ryan DH, Ard J, Kennedy BM. Effects of dietary patterns on blood pressure: subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial. Arch Intern Med. 1999;159:285-293.
25. Richardson SI, Freedman BI, Ellison DH, Rodriguez CJ. Salt sensitivity: a review with a focus on non-Hispanic blacks and Hispanics. J Am Soc Hypertens. 2013;7:170-179. doi: 10.1016/j.jash.2013.01.003.
26. Xin X, He J, Frontini MG, Ogden LG, Motsamai OI, Whelton PK. Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2001;38:1112-1117.
27. Jackson CL, Hu FB, Kawachi I, Williams DR, Mukamal KJ, Rimm EB. Black-White differences in the relationship between alcohol drinking patterns and mortality among US men and women. Am J Public Health. 2015;105(suppl 3):S534-S543. doi: 10.2105/AJPH.2015.302615.
28. Whelton PK. Sodium, blood pressure, and cardiovascular disease: a compelling scientific case for improving the health of the public. Circulation. 2014;129:1085-1087. doi: 10.1161/CIRCULATIONAHA.114.008138.
29. Lancaster KJ, Schoenthaler AM, Midberry SA, Watts SO, Nulty MR, Cole HV, Ige E, Chaplin W, Ogedegbe G. Rationale and design of Faith-based Approaches in the Treatment of Hypertension (FAITH), a lifestyle intervention targeting blood pressure control among black church members. Am Heart J. 2014;167:301-307. doi: 10.1016/j.ahj.2013.10.026.
30. Carter BL, Einhorn PT, Brands M, He J, Cutler JA, Whelton PK, Bakris GL, Brancati FL, Cushman WC, Oparil S, Wright JT Jr; Working Group from the National Heart, Lung, and Blood Institute. Thiazide-induced dysglycemia: call for research from a working group from the national heart, lung, and blood institute. Hypertension. 2008;52:30-36. doi: 10.1161/HYPERTENSIONAHA.108.114389.
31. Mujahid MS, Diez Roux AV, Cooper RC, Shea S, Williams DR. Neighborhood stressors and race/ethnic differences in hypertension prevalence (the Multi-Ethnic Study of Atherosclerosis). Am J Hypertens. 2011;24:187-193. doi: 10.1038/ajh.2010.200.
32. Brondolo E, Libby DJ, Denton EG, Thompson S, Beatty DL, Schwartz J, Sweeney M, Tobin JN, Cassells A, Pickering TG, Gerin W. Racism and ambulatory blood pressure in a community sample. Psychosom Med. 2008;70:49-56. doi: 10.1097/PSY.0b013e31815ff3bd.
33. The ALLHAT Officers and Coordinators for the ALLHAT Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981-2997.
34. Julius S, Alderman MH, Beevers G, Dahlöf B, Devereux RB, Douglas JG, Edelman JM, Harris KE, Kjeldsen SE, Nesbitt S, Randall OS, Wright JT Jr. Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE study. J Am Coll Cardiol. 2004;43:1047-1055. doi: 10.1016/j.jacc.2003.11.029.
35. Allan GM, Ivers N, Padwal RS. Best thiazide diuretic for hypertension. Can Fam Physician. 2012;58:653.
36. Wright JT Jr, Bakris G, Greene T, et al; African American Study of Kidney Disease and Hypertension Study Group. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA. 2002;288:2421-2431.
37. Rahman M, Pressel S, Davis BR, et al. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med. 2005;165:936-946. doi: 10.1001/ archinte.165.8.936.
38. Appel LJ, Wright JT Jr, Greene T, et al; African American Study of Kidney Disease and Hypertension Collaborative Research Group. Longterm effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans. Arch Intern Med. 2008;168:832-839. doi: 10.1001/ archinte.168.8.832.
39. McClellan WM, Warnock DG, Judd S, Muntner P, Kewalramani R, Cushman M, McClure LA, Newsome BB, Howard G. Albuminuria and racial disparities in the risk for ESRD. J Am Soc Nephrol. 2011;22:1721-1728. doi: 10.1681/ASN.2010101085.
40. Norris K, Bourgoigne J, Gassman J, Hebert L, Middleton J, Phillips RA, Randall O, Rostand S, Sherer S, Toto RD, Wright JT Jr, Wang X, Greene T, Appel LJ, Lewis J; AASK Study Group. Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial. Am J Kidney Dis. 2006;48:739-751. doi: 10.1053/j. ajkd.2006.08.004.
41. The SPRINT Research Group. Wright JT Jr., Williamson JD, Whelton PK, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373:2103-2116.
42. Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358:1547-1559.
43. Makani H, Bangalore S, Desouza KA, Shah A, Messerli FH. Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials. BMJ. 2013;346:f360.
44. Gutiérrez OM, Judd SE, Muntner P, Rizk DV, McClellan WM, Safford MM, Cushman M, Kissela BM, Howard VJ, Warnock DG. Racial differences in albuminuria, kidney function, and risk of stroke. Neurology. 2012;79:1686-1692. doi: 10.1212/WNL.0b013e31826e9af8.
45. Howard G, Lackland DT, Kleindorfer DO, Kissela BM, Moy CS, Judd SE, Safford MM, Cushman M, Glasser SP, Howard VJ. Racial differences in the impact of elevated systolic blood pressure on stroke risk. JAMA Intern Med. 2013;173:46-51. doi: 10.1001/2013.jamainternmed.857.
46. Muntner P, Whittle J, Lynch AI, Colantonio LD, Simpson LM, Einhorn PT, Levitan EB, Whelton PK, Cushman WC, Louis GT, Davis BR, Oparil S. Visit-to-visit variability of blood pressure and coronary heart disease, stroke, heart failure, and mortality: a cohort study. Ann Intern Med. 2015;163:329-338. doi: 10.7326/M14-2803.
47. Profant J, Dimsdale JE. Race and diurnal blood pressure patterns. A review and meta-analysis. Hypertension. 1999;33:1099-1104.
48. Beatty DL, Matthews KA. Unfair treatment and trait anger in relation to nighttime ambulatory blood pressure in African American and white adolescents. Psychosom Med. 2009;71:813-820. doi: 10.1097/ PSY.0b013e3181b3b6f8.
49. Steffen PR, McNeilly M, Anderson N, Sherwood A. Effects of perceived racism and anger inhibition on ambulatory blood pressure in African Americans. Psychosom Med. 2003;65:746-750.
50. Muntner P, Davis BR, Cushman WC, Bangalore S, Calhoun DA, Pressel SL, Black HR, Kostis JB, Probstfield JL, Whelton PK, Rahman M; ALLHAT Collaborative Research Group. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertension. 2014;64:1012-1021. doi: 10.1161/HYPERTENSIONAHA.114.03850.
51. Fontil V, Pletcher MJ, Khanna R, Guzman D, Victor R, Bibbins-Domingo K. Physician underutilization of effective medications for resistant hypertension at office visits in the United States: NAMCS 2006-2010. J Gen Intern Med. 2014;29:468-476. doi: 10.1007/s11606-013-2683-y.
52. Hypertension guideline working group; Seedat YK, Rayner BL, Veriava Y. South African hypertension practice guideline 2014. Cardiovasc J Afr. 2014;25:288-294. doi: 10.5830/CVJA-2014-062.
53. Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B, Shi V, Hester A, Gupte J, Gatlin M, Velazquez EJ; ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359:2417-2428. doi: 10.1056/ NEJMoa0806182.
54. Arnett DK, Boerwinkle E, Davis BR, Eckfeldt J, Ford CE, Black H. Pharmacogenetic approaches to hypertension therapy: design and rationale for the Genetics of Hypertension Associated Treatment (GenHAT) study. Pharmacogenomics J. 2002;2:309-317. doi: 10.1038/sj.tpj.6500113.
55. Turner ST, Boerwinkle E, O'Connell JR, et al. Genomic association analysis of common variants influencing antihypertensive response to hydrochlorothiazide. Hypertension. 2013;62:391-397. doi: 10.1161/ HYPERTENSIONAHA.111.00436.
56. Turner ST, Bailey KR, Schwartz GL, Chapman AB, Chai HS, Boerwinkle E. Genomic association analysis identifies multiple loci influencing antihypertensive response to an angiotensin II receptor blocker. Hypertension. 2012;59:1204-1211. doi: 10.1161/HYP.0b013e31825b30f8.
57. Del-Aguila JL, Beitelshees AL, Cooper-Dehoff RM, Chapman AB, Gums JG, Bailey K, Gong Y, Turner ST, Johnson JA, Boerwinkle E. Genomewide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans. Pharmacogenomics J. 2014;14:35-40. doi: 10.1038/tpj.2013.3.
58. Freedman BI, Cohen AH. Hypertension-attributed nephropathy: what's in a name? Nat Rev Nephrol. 2016;12:27-36. doi: 10.1038/nrneph.2015.172.
59. Parsa A, Kao WH, Xie D, et al; AASK Study Investigators; CRIC Study Investigators. APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med. 2013;369:2183-2196. doi: 10.1056/ NEJMoa1310345.
60. Freedman BI, Pastan SO, Israni AK, et al. APOL1 genotype and kidney transplantation outcomes from deceased African American donors. Transplantation. 2016;100:194-202. doi: 10.1097/ TP.0000000000000969.
61. Grams ME, Rebholz CM, Chen Y, Rawlings AM, Estrella MM, Selvin E, Appel LJ, Tin A, Coresh J. Race, APOL1 risk, and eGFR decline in the general population [Published online ahead of print March 10, 2016,]. J Am Soc Nephrol. doi: 10.1681/ASN.2015070763.
62. Einhorn PT. National heart, lung, and blood institute-initiated program "interventions to improve hypertension control rates in African Americans": background and implementation. Circ Cardiovasc Qual Outcomes. 2009;2:236-240. doi: 10.1161/CIRCOUTCOMES.109.850008.
63. Mueller M, Purnell TS, Mensah GA, Cooper LA. Reducing racial and ethnic disparities in hypertension prevention and control: what will it take to translate research into practice and policy? Am J Hypertens. 2015;28:699-716. doi: 10.1093/ajh/hpu233.
64. Carter BL, Rogers M, Daly J, Zheng S, James PA. The potency of teambased care interventions for hypertension: a meta-analysis. Arch Intern Med. 2009;169:1748-1755. doi: 10.1001/archinternmed.2009.316.
65. Dehmer SP, Baker-Goering MM, Maciosek MV, Hong Y, Kottke TE, Margolis KL, Will JC, Flottemesch TJ, LaFrance AB, Martinson BC, Thomas AJ, Roy K. Modeled Health and Economic Impact of Team-Based Care for Hypertension. Am J Prev Med. 2016;50(5 suppl 1):S34-S44. doi: 10.1016/j.amepre.2016.01.027.
66. Omboni S, Ferrari R. The role of telemedicine in hypertension management: focus on blood pressure telemonitoring. Curr Hypertens Rep. 2015;17:535. doi: 10.1007/s11906-015-0535-3.
67. Krousel-Wood MA, Muntner P, Islam T, Morisky DE, Webber LS. Barriers to and determinants of medication adherence in hypertension management: perspective of the cohort study of medication adherence among older adults. Med Clin North Am. 2009;93:753-769. doi: 10.1016/j.mcna.2009.02.007.
68. Ogedegbe G, Chaplin W, Schoenthaler A, Statman D, Berger D, Richardson T, Phillips E, Spencer J, Allegrante JP. A practice-based trial of motivational interviewing and adherence in hypertensive African Americans. Am J Hypertens. 2008;21:1137-1143. doi: 10.1038/ajh.2008.240.
69. Cooper LA, Roter DL, Carson KA, Bone LR, Larson SM, Miller ER 3rd, Barr MS, Levine DM. A randomized trial to improve patient-centered care and hypertension control in underserved primary care patients. J Gen Intern Med. 2011;26:1297-1304. doi: 10.1007/s11606-011-1794-6.
70. Oliveria SA, Lapuerta P, McCarthy BD, L'Italien GJ, Berlowitz DR, Asch SM. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med. 2002;162:413-420.
71. Kerr EA, Zikmund-Fisher BJ, Klamerus ML, Subramanian U, Hogan MM, Hofer TP. The role of clinical uncertainty in treatment decisions for diabetic patients with uncontrolled blood pressure. Ann Intern Med. 2008;148:717-727.
72. Ogedegbe G, Tobin JN, Fernandez S, Cassells A, Diaz-Gloster M, Khalida C, Pickering T, Schwartz JE. Counseling African Americans to Control Hypertension: cluster-randomized clinical trial main effects. Circulation. 2014;129:2044-2051. doi: 10.1161/CIRCULATIONAHA.113.006650.
73. National Information Center on Health Services Research and Health Care Technology NICHSR) 2016; http://www.nlm.nih.gov/hsrinfo/implementation science.html.
74. Navar-Boggan AM, Shah BR, Boggan JC, Stafford JA, Peterson ED. Variability in performance measures for assessment of hypertension control. Am Heart J. 2013;165:823-827.
75. Myers MG, Godwin M, Dawes M, Kiss A, Tobe SW, Kaczorowski J. Measurement of blood pressure in the office: recognizing the problem and proposing the solution. Hypertension. 2010;55:195-200. doi: 10.1161/ HYPERTENSIONAHA.109.141879.
76. Booth JN 3rd, Diaz KM, Seals SR, Sims M, Ravenell J, Muntner P, Shimbo D. Masked hypertension and cardiovascular disease events in a prospective cohort of blacks: The Jackson Heart Study. Hypertension. 2016;68:501-510. doi: 10.1161/HYPERTENSIONAHA.116.07553.
77. Din-Dzietham R, Liu Y, Bielo MV, Shamsa F. High blood pressure trends in children and adolescents in national surveys, 1963 to 2002. Circulation. 2007;116:1488-1496. doi: 10.1161/CIRCULATIONAHA.106.683243.